Medico Intercontinental schedules AGM for September 30, 2026

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Medico Intercontinental schedules AGM for September 30, 2026
  • Meeting will be held via VC/OAVM at 2:00 pm
  • Book closure runs from September 24 to September 30, 2026
  • Record date for e-voting is set for September 23, 2026
powered bylight_fuzz_icon
49969765

*this image is generated using AI for illustrative purposes only.

Medico Intercontinental has scheduled its Annual General Meeting for September 30, 2026. The meeting will be conducted via Video Conferencing or Other Audio Visual Means at 2:00 pm.

The Board of Directors approved the date during its meeting held on August 14, 2026. Shareholders holding equity shares as of the record date will be eligible to vote.

Key Dates

The company has defined specific timelines for the book closure and e-voting process to ensure smooth conduct of the meeting.

Event Date
Record Date for E-Voting September 23, 2026
Book Closure Start September 24, 2026
Book Closure End September 30, 2026

Regulatory Compliance

The register of transfer and register of members will remain closed from September 24, 2026, to September 30, 2026, both days inclusive. This action is taken pursuant to Regulation 42 of the SEBI (LODR) Regulations, 2015.

Samir D Shah, Managing Director, issued the intimation on behalf of the company.

Historical Stock Returns for Medico Intercontinental

1 Day5 Days1 Month6 Months1 Year5 Years
+1.41%-7.61%+3.48%-23.35%-25.51%0.0%

What specific resolutions or strategic initiatives are expected to be tabled for shareholder approval at the upcoming AGM?

How might the outcomes of the AGM, particularly regarding dividend declarations or board appointments, influence Medico Intercontinental's stock valuation in Q4 2026?

Are there any pending regulatory approvals or compliance issues from previous filings that shareholders should anticipate being addressed during the meeting?

Medico Intercontinental
View Company Insights
View All News
like16
dislike

Medico Intercontinental Q1 Results: Standalone profit rises 9% YoY to ₹60.8 lakh

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

Medico Intercontinental Limited reported Q1FY27 standalone net profit of ₹60.76 lakh, up 9% YoY. Consolidated results showed a net loss of ₹404.23 lakh on revenue of ₹2,084 lakh. The divergence highlights operational challenges within group subsidiaries.

powered bylight_fuzz_icon
48489728

*this image is generated using AI for illustrative purposes only.

Medico Intercontinental reported a standalone net profit of ₹60.76 lakh for the quarter ended June 30, 2026 (Q1FY27), an increase from the ₹55.60 lakh recorded in the corresponding period of FY25. The company’s standalone revenue from operations stood at ₹1,524.02 lakh, up from ₹1,370.86 lakh in Q1FY26.

The Board of Directors approved the unaudited financial results at its meeting held on August 14, 2026. The statutory auditors expressed an unmodified opinion on these results under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

Standalone earnings per share (EPS) were ₹0.61, compared to ₹0.56 in the same quarter last year. In the preceding quarter (Q4FY26), the company posted a net profit of ₹42.41 lakh on revenue of ₹1,655.31 lakh.

Metric: Q1FY27 (Standalone): Q1FY26 (Standalone):
Revenue: ₹1,524.02 lakh ₹1,370.86 lakh
Net Profit: ₹60.76 lakh ₹55.60 lakh
EPS (Basic): ₹0.61 ₹0.56

Consolidated results presented a different picture, with the group reporting a net loss of ₹404.23 lakh for the quarter, widening from the ₹248.80 lakh loss in Q1FY26. Consolidated revenue was ₹2,084.49 lakh, slightly down from ₹2,161.79 lakh in the prior year period.

What the Numbers Show

A significant divergence exists between the standalone and consolidated performance. While the parent entity generated a modest profit, the consolidated group incurred a substantial loss of ₹404.23 lakh despite higher consolidated revenues. This suggests that subsidiaries or associates within the group are currently operating at a loss, dragging down the overall group profitability despite the standalone unit's positive contribution.

Historical Stock Returns for Medico Intercontinental

1 Day5 Days1 Month6 Months1 Year5 Years
+1.41%-7.61%+3.48%-23.35%-25.51%0.0%

Which specific subsidiaries or associates are contributing to the widened consolidated loss of ₹404.23 lakh, and what is the management's strategy to turn them profitable?

How does the divergence between standalone profitability and consolidated losses impact Medico Intercontinental's overall valuation and investor confidence?

What operational cost drivers or one-time expenses caused the consolidated net loss to widen significantly from ₹248.80 lakh in Q1FY26 to ₹404.23 lakh in Q1FY27?

Medico Intercontinental
View Company Insights
View All News
like17
dislike

More News on Medico Intercontinental

1 Year Returns:-25.51%